Applied Molecular Transport Inc.

Applied Molecular Transport Inc. (Nasdaq: AMTI), relating to its proposed sale to Cyclo Therapeutics, Inc. Under the terms of the agreement, AMTI shareholders are expected to receive 0.174 shares of Cyclo per share they own.

To receive more information regarding the investigation of Applied Molecular Transport Inc. please fill out the form below.